Foerch, C., Singer, O., Neumann-Haefelin, T., et al. (2005) Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Archives of Neurology, 62, 1130-1134.
 Foerch, C., Curdt, I., Yan, B., et al. (2006) Serum glial fibrillary acidic protein as a biomarker for intracerebral haemor-rhage in patients with acute stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 77,181-184.
 Herrmann, M., Vos, P., Wunderlich, M., et al. (2000) Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke, 31, 2670-2677.
 Wilhelmsson, U., Li, L., Pekna, M., et al. (2004) Absence of glial fibrillary acidic protein and vimentin prevents hy-per-trophy of astrocytic processes and improves post- traumatic regeneration. Journal of Neuroscience, 24, 5016- 5021.
 Si, X., Miguel-Hidalgo, J., O’Dwyer, G., et al. (2004) Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology, 29, 2088-2096.
 Webster, M., Knable, M., Johnston-Wilson, N., et al. (2001) Immunohistochemical localization of phosphory-lated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bi-polar disorder, and depression. Brain, Behavior, and Im-munity, 15, 388-400.
 Poletaev, A.B., Morozov, S.G., Gnedenko, B.B., et al. (2000) Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental neurological disorders.Autoimmunity, 32, 33-38.
 Sanna, G., Piga, M., Terryberry, J.W., et al. (2000) Central nervous system involvement in systemic lupus ery-thematosus: Cerebral imaging and serological profile in patients with and without overt neuropsychiatric manife-stations. Lupus, 9, 573-583.
 Melehov, M.G., Ruleva, N.Yu., Lyucova, T.K. and Dugin, S.F. (2004) Potentiating effect of nicotine on inflammation and induction of autoantibodies in rats. Russian Physiological Journal named after Sechenov, 90, 638- 644.
 Ruleva, N.Yu., Kuzin, V.M., Kamchatnov, P.R., et al. (2004) Markers of inflammation, autoantibodies to neu-rospecific antigens and outcome in patients with acute ischemic stroke. Journal of Neurology and Psychiatrics, 12, 43-47.
 Magri, G., Clerici, M., Dall’Ara, P., et al. (2005) Decrease in pathology and progression of scrapie after im-munisation with synthetic prion protein peptides in ham-sters. Vaccine, 23, 2862-2868.
 Ishida, K., Kaneko, K., Kubota, T., et al. (1997) Identifi-cation and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder. Journal of the Neurological Sciences, 151, 41-48.
 Dambinova, S., Khounteev, G., Izykenova, G., et al. (2003) Blood test detecting autoantibodies to N-methyl- D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clinical Chemistry, 49, 1752-1762.
 Ruleva, N.Yu., Dugin, S.F., Kamchatnov, P.R., Lyukova, T.K., Chugunov, A.V., Martynov, M.Yu and Gusev, E.I. (2005) Autoantibodies to dopamine and outcome after acute ischemic stroke. Neuroimmunologia, 3, 22-25.
 Becker, K., Kindrick, D., Lester, M., et al. (2005) Sensi-tization to brain antigens after stroke is augmented by li-popolysac-charide. Journal of Cerebral Blood Flow & Metabolism, 25, 1634-1644.